Focused examination of sentinel lymph nodes upstages early colorectal carcinoma

American Surgeon

Volumn 66, Issue 11, 2000, Pages 998-1003

  Wood, T F ^a   Tsioulias, G J ^a   Morton, D L ^a   Rangel, D ^a   Hutchinson W , Jr ^a   Foshag, L J ^a   Turner, R R ^a   Bilchik, A J ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN; EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CANCER STAGING; COLON RESECTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PREDICTION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 0033767128     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cancer statistics, 1999
2. Adjuvant therapy for colorectal cancer
3. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49: Correlation with long-term survival
4. Micrometastases and survival in stage II colorectal cancer
5. Detection of occult nodal metastases in patients with colorectal carcinoma
6. Micrometastasis in colorectal carcinoma: A review
7. Genetic detection of lymph node micrometastases in patients with colorectal cancer
8. Technical details of intraoperative lymphatic mapping for early stage melanoma
9. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial
10. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
11. Improved axillary staging of breast cancer with sentinel lymphadenectomy
12. Sentinel lymphadenectomy in thyroid malignant neoplasms
13. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms
14. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging
15. Accurate staging of colorectal cancer by sentinel lymph node mapping: A prospective study
16. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma
17. Accuracy of diagnosis of micrometastases in colorectal cancer by sentinel lymph node mapping technique
18. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
19. Adjuvant therapy for patients with colon and rectal cancer
20. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate Advanced Colorectal Cancer Meta-Analysis Project
21. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators
22. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project protocol C-03
23. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
24. Fluorouracil, leucovorin and levamisole adjuvant therapy for colon cancer: Five-year final report of INT-0089
25. The relative efficacy of 5-FU + leucovorin, 5-FU + levamisole, and 5-FU + levamisole + leucovorin in patients with Duke's B and C carcinoma of the colon: First report of the NSABP C-04
26. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer
27. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01
28. Effect of postoperative radiation therapy when used with adjuvant chemotherapy in Duke's B and C rectal cancer: Results from NSABP R-02
29. Therapy for early-stage colorectal cancer
30. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: Results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)
31. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator